Profilo
Mark T.
Tengler is the founder of Spectrix Therapeutics LLC, which is founded in 2016, where he holds the title of Chief Executive Officer.
He also held the position of Chief Technology Officer at Neos Therapeutics, Inc. from 2014 to 2016.
Prior to that, he worked as Operations Director at PharmaPrint, Inc. Mr. Tengler received his undergraduate degree from Colorado State University.
Posizioni attive di Mark Tengler
| Società | Posizione | Inizio |
|---|---|---|
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Amministratore Delegato | 01/01/2016 |
Precedenti posizioni note di Mark Tengler
| Società | Posizione | Fine |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Presidente | - |
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology Develop dietary supplement, functional food and pharmaceutical products from botanical sources | Direttore operativo | - |
Formazione di Mark Tengler
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology Develop dietary supplement, functional food and pharmaceutical products from botanical sources | Health Technology |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
















